【摘要】 目的评价肺血栓栓塞症(PTE)临床路径的效果。方法选取2011~2012年该呼吸内科收治住院的PTE患者60例,分为试验组和对照组,每组30例。对照组按普通流程进行住院管理;实验组按制定的临床路径实施住院管理。记录并比较分析两组的疗效、住院时间、住院总费用、药品费用、住院期间出现并发症的情况以及患者对此次住院的满意度。结果试验组的平均住院时间、平均住院费用与平均药品费用分别为(17.13±2.22)d、(16 545.04±1 557.44)元与(7 050.83±372.74)元,均少于对照组的(19.77±3.41)d、(17 709.45±1 902.05)元与(7 345.75±450.82)元,两组比较差异均有统计学意义(均P<0.05);试验组和对照组的满意度分别为(93.47±3.88)分与(90.90±5.30)分,两组间比较差异有统计学意义(P<0.05)。两组间的治疗效果与并发症发生率比较,差异均无统计学意义(均P>0.05)。结论 PTE临床路径的开展对缩短住院时间、节约住院费用和药品费用以及提高患者满意度均有积极作用,值得临床推广。更多还原

【Abstract】 Objective To evaluate the effect of clinical pathway in pulmonary thrombus embolism(PTE).Methods 60cases of PTE were admitted department of respiratory from 2011to 2012and divided into the experimental group and the control group,30 cases for each group.The control group was implemented with normal process of hospital management while experimental group developed clinical pathways.The efficacy,department of respiratory drug costs,complications and patient satisfaction were recorded and computed.Results The average department of respiratory and drug costs in experimental group respectively was(17.13± 2.22)days,(16 545.04±1 557.44)RMB and(7 050.83±372.74)RMB;less than(19.77±3.41)day,(17 709.45±1 902.05) RMB and(7 345.75±450.82)RMB in control group,there were significant difference between the two groups(P<0.05).The satisfaction scores of experimental group and the control group respectively were(93.47±3.88)sores and(90.90±5.30)scores, there was significant difference between the two groups(P<0.05).The therapeutic effect and complication rates between experimental group and control group were no significant difference(P>0.05).Conclusion The effect of clinical pathway in PTE have a positive role in reducing hospitalization time,total costs,drug costs and increasing satisfaction,it is worth to develop in primary hospital.更多还原